Clinical Trials · NCT04941521
Exenatide for Treating Cocaine Use Disorder
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- The University of Texas Health Science Center, Houston
- Enrollment
- 3
- Start date
- Jun 2021
- Locations
- 1 site, United States
- Primary endpoint
- Feasibility as Assessed by Number of Participants Who Completed Treatment